U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413536) titled 'A Phase Ia Single Ascending-Dose Study of Subcutaneous EB070 Injection in Healthy Volunteers' on Jan. 30.
Brief Summary: The goal of this Phase Ia clinical trial is to evaluate the safety, tolerability, and pharmacokinetics of EB070 injection following single ascending subcutaneous doses in healthy adult volunteers.
The main questions it aims to answer are:
Is EB070 injection safe and well tolerated at increasing single subcutaneous dose levels in healthy subjects?
What are the pharmacokinetic characteristics of EB070 after single-dose administration?
This is a single-center, randomized, double-blind, placebo-controlled, single ...